Delirium is associated with a host of negative outcomes, including increased risk of mortality, longer hospital stay, and poor long-term cognitive function. The pathophysiology of delirium is not well understood. Cancer patients undergoing a bone marrow transplant (BMT) are at high risk for developing delirium and Proton Magnetic Resonance Spectroscopy ( 1 H MRS) could lead to better understanding of the delirium process. Fourteen BMT patients and 10 controls completed 1 H MRS, positioned above the corpus callosum, shortly after delirium onset or at study end if no delirium occurred. In the BMT-delirium group, statistically significantly elevated tCho/tCr was found in contrast to the BMT-no delirium group. The BMT-delirium group also showed statistically significantly lesser NAA/tCho compared with both controls and the BMT-no delirium group. Elevated choline and reduced NAA indicate inflammatory processes and white matter damage as well as neuronal metabolic impairment. Further research is needed to separate the choline peaks, as well as more detailed collection of medication regimens to determine whether a higher choline concentration is a function of the delirium process or cancer treatment effects.
Introduction
Delirium is a disturbance of consciousness caused by a medical condition and characterized by rapid onset, fluctuating course and change in cognition. Delirium is assessed by a clinician using criteria from the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition [DSM-IV] (APA, 2000) or a validated screening instrument, both of which involve in-person interviewing of the patient. Delirium is associated with a host of negative outcomes, including increased risk of mortality, longer hospital stay, and poor long-term cognitive function (van Hemert et al., 1994; Beglinger et al., 2006; Fong et al., 2009) . Additionally, patients with delirium may not accurately report physical symptoms, which may impact treatment decisions, such as appropriate medical management of pain. Delirium is common in cancer patients, but it is under-recognized and under-treated, particularly early in its course when it may be mistaken for anxiety about treatment or side effects. Certain risk factors have been identified, such as age, elevated blood urea nitrogen level, cognitive impairment, and use of opioids, but the underlying mechanism of delirium is unknown.
Proton Magnetic Resonance Spectroscopy ( 1 H MRS) has become a valuable tool in the study of both cancer and psychiatric disorders. 1 H MRS can measure levels of metabolites such as N-acetyl aspartate (NAA), trimethylamines, such as phosphocholine, glycerophosphocholine and choline (tCho), total creatine (tCre = phosphocreatine + creatine), myo-inositol (mI), and glutamate (Glu, containing both neurotransmitter glutamate and metabolic glutamate). These metabolites are essential for various cell processes and we are just beginning to understand their functions. TCre reflects high energy phosphate metabolism, and has been used as a reference value in many studies. NAA is selectively concentrated in neurons and numerous studies have shown NAA/Cr decrease in neurodegenerative diseases suggesting neuronal loss (Birken and Oldendorf, 1989) . The choline peak in 1 H MRS consists of contributions from mainly glycerophosphocholine (GPC) phosphocholine (PC), and typically a small amount of free choline and is regulated by activity of phospholipase A2 (Boulanger et al., 2000) , phosphodiesterphosphodiesterase and phosphodiesterphosphomonoesterase. Therefore, in 1 H MRS in 3 T fields, the peak is referred to as total choline (tCho). Total choline is thought to represent an increase in membrane turnover, with increased GPC indicating membrane degradation and increased PC being a precursor to membrane synthesis (e.g., found in replicating cancers). Only 31 P MRS can separate these signals to determine their relative contributions to tCho abnormalities as might be seen with disparate pathological conditions (e.g., tumors, demyelination, and inflammatory processes) (Brenner et al., 1993) . Myo-inositol has been used as a glial marker and may be involved with inflammation. Glutamate (Glu) is the highest concentrated amino acid in the brain, 
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